Endoscopic Devices - Benelux | Statista Market Forecast

Revenue in the Endoscopic Devices market market in Benelux is anticipated to attain US$553.80m in 2024.
The revenue is projected to experience an annual growth rate (CAGR 2024-2029) of 6.88%, leading to a market volume of US$772.20m by 2029.
In a global context, the highest revenue will be produced the United States, where it is expected to reach US$10.39bn in 2024.
In the Benelux region, the demand for advanced endoscopic devices is increasingly driven by a growing emphasis on minimally invasive surgical procedures and patient recovery.

Definition:
The Endoscopic Devices market, a medical technology market, includes the sale of endoscopic devices. Endoscopy involves the use of an endoscope to examine the inside of a hollow organ or body cavity. The market includes various types of endoscopes, such as gastroscopes, laparoscopes, bronchoscopes, and colonoscopes.

Additional information:
Market values represent revenues paid to primary vendors at manufacturer price level either directly or through distribution channels (excluding VAT). Reported market revenues include spending by consumers (B2C), enterprises (B2B), and governments (B2G). Revenues are allocated to the country where the money is spent.

Key players in the market include Olympus Corporation, Boston Scientific Corporation, and Stryker Corporation. Further information on the key players can be found in the Market Shares boxes.

Endoscopic devices
Implants such as stents

pharmaceuticals for endoscopic procedure

The Endoscopic Devices Market within the Medical Devices sector in Benelux is witnessing moderate growth, influenced by factors such as advancements in technology, increasing prevalence of gastrointestinal disorders, and rising demand for minimally invasive procedures among healthcare providers.

Customer preferences: Consumers in the Benelux region are increasingly favoring minimally invasive surgical options, reflecting a broader trend towards personalized healthcare and quick recovery times. This shift is influenced by an aging population seeking less traumatic procedures and a growing awareness of gastrointestinal health. Additionally, the rise of telemedicine has empowered patients to seek timely interventions, further driving demand for advanced endoscopic devices. Cultural preferences for less invasive treatments are reshaping the landscape of the medical technology market.

Trends in the market: In the Benelux region, the Endoscopic Devices Market is experiencing a surge in demand for advanced minimally invasive surgical technologies, driven by an aging population that prioritizes faster recovery and reduced hospital stays. The increasing prevalence of gastrointestinal disorders is further propelling innovation in endoscopic procedures. Additionally, the integration of digital technologies, including AI-assisted diagnostics and remote patient monitoring, is enhancing the efficacy of these devices. This shift not only improves patient outcomes but also presents significant opportunities for manufacturers and healthcare providers to expand their service offerings and improve operational efficiencies.

Local special circumstances: In the Benelux region, the Endoscopic Devices Market is shaped by a robust healthcare infrastructure and strong regulatory frameworks that prioritize patient safety and innovation. The cultural emphasis on preventive healthcare drives demand for early diagnosis and minimally invasive procedures. Additionally, the region's collaborative approach to healthcare, involving public and private sectors, fosters research and development in advanced endoscopic technologies. Geographic proximity to leading medical technology hubs facilitates knowledge exchange and enhances market competitiveness, further propelling growth in this sector.

Underlying macroeconomic factors: The Endoscopic Devices Market in the Benelux region is significantly influenced by macroeconomic factors such as national economic stability, healthcare expenditure, and regulatory policies. Strong economic performance in countries like Belgium, the Netherlands, and Luxembourg promotes increased investment in healthcare infrastructure, facilitating the adoption of advanced endoscopic technologies. Additionally, fiscal policies that prioritize healthcare funding and innovation support the development and commercialization of new devices. Global economic trends, including an aging population and rising prevalence of chronic diseases, further boost demand for minimally invasive procedures, enhancing market growth prospects.

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on medical devices and IVD revenues allocated to the country where the money is spent at manufacturer price levels excluding VAT.

Modeling approach / Market size:

Modeling employs a top-down approach with a bottom-up validation, using financial information of the key players by market. Market sizes are determined by a top-down approach, based on a specific rationale for each market market and allocated to the covered countries according to the global market shares. As a basis for evaluating markets, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare system, and regulations concerning medical products. Next, we use further relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare payer system, and regulations concerning medical products. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

Medical technology plays a role in the lives of everyone. It includes most of all, medical devices which simplify the prevention, diagnosis, and treatment of diseases and illnesses. The most well-known medical technology products are, among others, pacemakers, imaging instruments, dialysis machines, and implants. The global medical technology industry was worth over 567 billion U.S. dollars annually. Established centers of this industry include North America and Western Europe. The United States is home to the world’s largest medical technology companies. As of 2022, Abbott Laboratories had the largest global revenue at over 31.2 billion U.S. dollars. The main focus of devices manufactured by the Chicago-based company are diagnostics, cardiovascular, and diabetes care. Two other medtech companies that round off the top three largest companies –Medtronic and Johnson & Johnson – are both based in the United States. Although, industry trends show that Asia, and in particular China, is about to play a more prominent role in the years to come.